Lighthouse Pharmaceuticals
Novato, US · Founded 2022 · Delaware corporation · 2 known investors
Founders & leadership
Lighthouse Pharmaceuticals was founded in 2022 by Casey Lynch.
CL
Casey LynchinFounder
SD
Stephen DominyNamed on SEC filing
Board
CM
Campbell MurrayBoard director
Investors · 2
Also in the syndicate · 1
Double Point Ventureslead
Reported raises · per SEC filings
Form D private placements$15.2M disclosed across 1 round · 2026
▶$15.2MraisedMay 2026 · 25 investors · OtherRule 506(b)
▶$15.2MraisedMay 2026 · 25 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Campbell MurrayDirector
- Stephen DominyDirector
- Casey LynchExecutive Officer, Director, Promoter
- Offering amount
- $15.2M
- Amount sold
- $15.2M
- First sale
- Apr 2026
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Lighthouse Pharmaceuticals Raises $12M Series A to Advance Alzheimer’s Therapy | citybizcitybiz.co · Apr 2026
Lighthouse Pharmaceuticals Raises $12M in Series A Fundingfinsmes.com · Apr 2026Frequently asked questions
- Who founded Lighthouse Pharmaceuticals?
- Lighthouse Pharmaceuticals was founded by Casey Lynch in 2022.
- Who are Lighthouse Pharmaceuticals's investors?
- Lighthouse Pharmaceuticals's investors include Marin Sonoma Impact Ventures.
- How much funding has Lighthouse Pharmaceuticals raised?
- Lighthouse Pharmaceuticals has disclosed $15.2M raised across 1 round.
- Where is Lighthouse Pharmaceuticals headquartered?
- Lighthouse Pharmaceuticals is headquartered in Novato, US.